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H3 antagonists and itch
Histamine H3 receptors regulate histamine synthesis and ⁄ or release in several tissues,
such as the brain, lung, spleen, colon and peripheral sensory nerve endings.
Intradermal injection of H3 antagonists induced scratching behaviour in both mast
cell-deﬁcient and wild type-mice. The results indicated that intradermal injection of H3
antagonists induces scratching behaviour and that chemical mediators other than
histamine seem to be involved in the response. These may be useful ﬁndings for the
development of new antipruritic drugs.
HossenMA, SugimotoY, KayasugaR, Kamei C. Involvement of histamineH3 receptors in
scratching behaviour in mast cell-deficient mice. Br J Dermatol 2003; 149: 17–22.
Methotrexate works in psoriasis – but how?
The mechanisms by which a low dose of methotrexate (MTX) works in psoriasis are not
clear. The effects of MTX at concentrations comparable to in vivo levels after the administration of low-dose
MTX on human umbilical vein endothelial cells (HUVEC) on the growth and expression of intercellular
adhesion molecule-1 (ICAM-1) and vascular cell adhesion molecule-1 (VCAM-1) were studied by Yamasaki
et al. MTX inhibited the proliferation of HUVEC at 10)7 M and 10)6 M without showing cytotoxic effects. It
also inhibited TNF-a-induced ICAM-1 and VCAM-1 expression by HUVEC at 10)6 M.
Yamasaki E, Soma Y, Kawa Y, Mizoguchi M. Methotrexate inhibits proliferation and regulation of the
expression of intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 by cultured
human umbilical vein endothelial cells. Br J Dermatol 2003; 149: 30–38.
EBS cells quicker off the mark?
To generate tools for testing new EBS therapies, Morley and colleagues immortalized keratinocytes frommild
and severe cases expressing different mutations in K5 or K14 keratins. Cells were assessed for variable
aspects of their behaviour that might mirror disease severity and provide a surrogate marker for therapeutic
assays. Such correlation was found in the rate of scratch wound closure when severe mutants moved faster
than milder mutants or controls. D’Alessandro et al. recently described up-regulation of stress activated
kinases in these cells; perhaps the constant need to handle mutant protein primes them for more rapid stress
responses.
Morley SM, D’Alessandro M, Sexton C et al. Generation and characterization of epidermolysis bullosa
simplex cell lines: scratch assays show faster migration with disruptive keratin mutations. Br J Dermatol
2003; 149: 46–58.
Human papillomavirus and Australian skin cancer patients
The healthy skin harbours a broad spectrum of human papillomavirus (HPV) types. In
addition to ultraviolet light, HPV may act as a cofactor in the development of non-
melanoma skin cancer. Forslund and coworkers studied 59 Australian skin cancer
patients and found totally 46 different HPV types in skin tumours and healthy skin.
HPV types associated with epidermodysplasia verruciformis predominated. No speciﬁc
HPV type could be identiﬁed in non-melanoma skin cancer, but HPV type 38 was
found signiﬁcantly more often in the presumed premalignant solar keratosis than in
squamous cell carcinomas (SCC). However, the role of HPV in the pathogenesis of
non-melanoma skin cancer remains elusive.
Forslund O, Ly H, Reid C, Higgins G. A broad spectrum of human papillomavirus is
present in the skin of Australian patients with non-melanoma skin cancers and
solar keratosis. Br J Dermatol 2003; 149: 64–73.
Contact allergy to antimicrobials in atopic eczema
Atopic eczema is often colonized by Staphylococcus aureus. Hence, topical therapy includes different antimicrobial agents. Jappe et al. investigated
the frequency of contact allergy to various such agents, comparing patients with current or past atopic eczema and controls, patch tested
1995–99, in a multifactorial analysis adjusted for age and sex. They found that patients with atopic eczema did not have a generally higher risk for
contact sensitization to antiseptics or antibiotics compared to non-atopic individuals. Thus their data do not support an overly restrictive use of
these agents in the management of atopic eczema.
Jappe U, Schnuch A, Uter W. Frequency of sensitization to antimicrobials in patients with atopic eczema compared with non-atopic individuals:
analysis of multicentre surveillance data, 1995–99.
Br J Dermatol 2003; 149: 87–93.
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RESEARCH SNIPPETS
The JID is pleased to publish Snippets from the British Journal of Dermatology. We hope you will find this monthly
feature useful; it will highlight articles of potential interest to JID readers.  In return, the BJD will publish Clinical
Snippets from each months JID. We are excited about this cooperative effort and welcome similar content-sharing 
projects with other journals. Abstracts for all JID and BJD articles are available without cost at the Synergy site:
http://www.blackwell-synergy.com. 
